StockStory.org on MSN
Why are Novavax (NVAX) shares soaring today
What Happened? Shares of vaccine biotechnology company Novavax (NASDAQ:NVAX) jumped 19.7% in the afternoon session after the ...
Long-term data suggest Moderna’s personalized melanoma shot provides “durable tumor control,” one analyst said. Elsewhere, ...
Maryland-based Novavax signed a licensing agreement allowing Pfizer access to its technology that boosts immune responses to ...
Zacks Investment Research on MSN
Novavax grants license for use of Matrix-M adjuvant to Pfizer
Novavax NVAX announced a non-exclusive license agreement with Pfizer PFE, granting the latter access to its proprietary ...
Health Canada is planning to speed up reviews of some drugs by piggybacking on the decisions of foreign regulators, including ...
Novavax said on Tuesday it signed a licensing agreement allowing Pfizer access to its technology that boosts immune ...
Houston Methodist, which Mary Bowden sued for defamation after it suspended her admitting privileges, "collects up to ...
Novavax (NVAX +3.02%) was once a leading contender to dominate the coronavirus vaccine market. The company faced several challenges, however, and although it successfully launched its vaccine, ...
Shares of two major Covid-19 vaccine makers declined Monday after a Food and Drug Administration official claimed the shots led to 10 children’s deaths and said the agency would tighten ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results